New drug MTX-101 enters first human safety trials for type 1 diabetes
Disease control
Recruiting now
This early-stage study tests a new drug called MTX-101 in healthy adults and people with type 1 diabetes. The main goal is to check for side effects and see how the drug moves through the body. Researchers will also look at how MTX-101 affects immune cells. The study involves up …
Phase: PHASE1 • Sponsor: Mozart Therapeutics Australia Pty Ltd • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC